Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
Dr Necchi graduated in Medicine with honours at the University of Milan in 2004. From 2005 to 2008 he did his postdoctoral specialisation in Medical Oncology at the same University and a fellowship in Medical Oncology at the Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, where from 2009 to 2011 he was assistant attending medical oncologist in Urologic Oncology.
Dr Necchi achieved the European Certification in Medical Oncology (ESMO) in 2006 and the certification by the Italian Board of Medical Oncology in 2008.
Dr Necchi’s research interest focuses on the medical treatment of germ-cell tumours and other genitourinary malignancies, including novel drugs and experimental therapies. He has been Principal Investigator and Co-investigator of several clinical studies.
Since 2011 he has been working for the Urologic Oncology Faculty at the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Since 2013 Dr Necchi has been Treasurer of the EORTC Genitourinary Cancers Group. He is member of the Penile Cancer Guidelines Panel at the European Association of Urology (EAU) and since 2015 he has been member of the ESMO Faculty Group in Genitourinary cancers and Member of the ESMO OncologyPRO Working Group. He is also a member of other scientific societies such as ASCO, the American Urological Association (AUA), the Society of Urologic Oncology (SUO).
Dr Necchi has received several awards such as, in 2010, the Young Researchers Award in Medical Oncology by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, in 2011 the 1st Gianni Bonadonna Prize for New Drug Development in Oncology by the Michelangelo Foundation, Milan, in 2012 and 2013 the merit award in Urothelial Cancer and in 2015 in Germ Cell Tumours by the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO).
He has been invited speaker to many International congresses, and he is author and co-author of over 90 articles in peer-reviewed journals.